Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
about
High-throughput sequencing of immune repertoires in multiple sclerosisUpdate on mesenchymal stem cell-based therapy in lupus and sclerodermaSCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobankingStem cell therapy for diabetes mellitusHematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary InvolvementAutologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcomeCapillary regeneration in scleroderma: stem cell therapy reverses phenotype?Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile?Anti-CD52 antibody-mediated immune ablation with autologous immune recovery for the treatment of refractory juvenile polymyositis.Immunological characteristics and T-cell receptor clonal diversity in children with systemic juvenile idiopathic arthritis undergoing T-cell-depleted autologous stem cell transplantation.Stem cell transplantation for autoimmune diseases.Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS.Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's diseaseQuantitative tracking of T cell clones after haematopoietic stem cell transplantation.Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.Brief report: Autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the Teff cell compartmentAcute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient.Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.Remitting-relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab.Reversal of age-related thymic involution by an LHRH agonist in miniature swineRenal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial.New approaches in the management of multiple sclerosis.The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.Haematopoietic stem cell transplantation for autoimmune diseases.Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients.Remission of refractory Crohn's disease after autologous hematopoietic stem cell transplantationExperimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a rQuantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.Signal joint T-cell receptor excision circle assay in miniature swine.Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantationCell therapy for autoimmune diseasesHigh-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot studyHaematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow TransplantationA prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.
P2860
Q26747682-636AFEDD-C186-45AA-A896-9B8AE2418568Q26777402-9B70EDEA-E548-4532-845E-2615CFC6DA85Q26853573-CF014A89-05F1-416A-AC38-B703AD8E04F4Q27011453-16B64CDF-5F34-4BA2-9D09-2C4F72D9CFE5Q28071992-7C530170-3775-43B7-8878-31A51ACB3E56Q28080076-33BE815E-A824-457C-B676-171B3C319842Q28253681-3F5DAFB2-9FD5-4014-AD53-0A047BDAB25EQ33314922-2A80AAB4-B67B-4907-A321-2D263A22F5B2Q33373065-154952E7-F241-4BFE-ABEC-6674A52A3FAAQ33380269-697B6C00-F0C0-4E83-9B7F-E003B716CD73Q33395186-02721E13-C33F-4236-8D53-68E7A1596B93Q33559048-6848FC59-9BA0-4A9C-AE0A-6A0164C79007Q33632194-FB13104F-7B72-4A03-BBD6-69C7F16A1474Q33632260-76165417-E9A4-4F7A-AE01-36C743BA4D60Q33632470-000F412C-8126-4F53-9817-8880EB3F3747Q33768359-EDD8E9C0-4C9E-43A4-BC8A-BDBBC1A943ECQ33837175-30EC847A-51B6-4821-B7F9-EF0F2ED646C4Q33965239-5A1B8861-1C0D-4FAC-9379-C42C2378DF62Q34039955-530E0CE5-6FC1-4B9C-BF44-64A791852F1AQ34182038-C4EF05EA-A0D6-491E-849D-4913F5E39525Q34230150-81CD0283-3B45-4728-B19C-E437C4290B70Q34231394-497058A5-3123-4509-9D7B-548F94DC1289Q34336209-B98D5F43-C58E-4C1C-A296-CAB6FF412D58Q34372648-FC298C94-468E-41D0-972D-B81854E0D157Q34389528-41AC7399-CAF9-40DF-A8F4-DB035BB0C813Q34500124-E47455F2-5B98-4353-8F1A-EFDD23E94963Q34551863-0E5B3657-6B99-48C1-90CE-52AA46278DB4Q35087069-DA8E8037-B09C-4CA9-8F39-3790C231CA15Q35244368-3774F84D-9732-41AE-BDFD-7154C10C15DAQ35589934-54237798-C417-404B-A132-90D225830DDDQ35638755-FDC125B2-66C4-4743-89EC-90DDDC2E52C0Q35661328-B08CA653-62F2-4872-AA4A-F41074CD4ACFQ35793135-B68FE4EF-2E98-4703-9F24-F641B06A2CB2Q35804518-39BB63CB-C646-4FAF-8C4D-050A8FD8463CQ35868954-A342A40D-EA27-4DDD-A036-1F2F6DEF4CE1Q35925071-3FEB9D7A-DB85-46CD-AE12-086A0FF22EB7Q36020897-ED9D7319-ACF6-4DE0-9ED4-DC7E45C56AE4Q36075481-AC2ED6A0-BAD1-4B19-8E8B-C73B64384D45Q36228011-94627713-C613-4595-BB2C-A13D99FF6C7BQ36252940-5441DC4C-FD67-4CE6-9555-7F413DC3B88A
P2860
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Thymic output generates a new ...... n multiple sclerosis patients.
@ast
Thymic output generates a new ...... n multiple sclerosis patients.
@en
type
label
Thymic output generates a new ...... n multiple sclerosis patients.
@ast
Thymic output generates a new ...... n multiple sclerosis patients.
@en
prefLabel
Thymic output generates a new ...... n multiple sclerosis patients.
@ast
Thymic output generates a new ...... n multiple sclerosis patients.
@en
P2093
P2860
P50
P356
P1476
Thymic output generates a new ...... in multiple sclerosis patients
@en
P2093
Amy Packer
Catherine Campbell
Daniel C Douek
Frances T Hakim
Francisco J Guenaga
Henry F McFarland
James W Nagle
Katherine Chung
Riccardo Cassiani-Ingoni
Richard K Burt
P2860
P304
P356
10.1084/JEM.20041679
P407
P577
2005-02-28T00:00:00Z